Background Drug-induced liver injury (DILI) is the most challenging and thought-provoking
liver problem for hepatologists owing to unregulated medication usage in medical practices …

Liposomal formulations, as versatile nanocarrier systems suitable for targeted delivery, have
a highly focused role in the therapy development of unmet clinical needs and diagnostic …

Alcohol-associated liver disease (ALD) is a common chronic liver disease and major
contributor to liver disease-related deaths worldwide. Despite its pre-valence, there are few …

Costunolide (cos) derived from the roots of Dolomiaea souliei (Franch.), which belongs to
the Dolomiaea genus in the family Compositae, exert the anti‐inebriation effect mainly by …

Background: To comprehensively evaluate the treatment efficacy and safety of silymarin for
patients with glucose/lipid metabolic dysfunction using a meta-analysis. Methods: A …

Objectives Alzheimer's disease (AD) is a neurological disorder that causes dementia and a
progressive loss of thinking, social, and memory abilities. Afterwards, this worsening induces …

Catechin is an active ingredient of green tea. It is reported to inhibit corticosteroid‑induced
anxiety and depression‑like symptoms. Considering the complex nature of depression …

Synthesis, characterization and hepatoprotective effect of silymarin phytosome nanoparticles
on ethanol-induced hepatotoxicity in rats - PMC Back to Top Skip to main content NIH NLM …

Silymarin is a standardized extract obtained from seeds of Silybum marianum (SM)
belonging to the family Asteraceae. It is a flavonolignan complex and consists of various …

Liver disorders present a significant global health challenge, necessitating the exploration of
innovative treatment modalities. Liposomal nanocarriers have emerged as promising …